Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
75.05
-1.00 (-1.31%)
At close: Aug 18, 2025, 4:00 PM
73.99
-1.06 (-1.41%)
After-hours: Aug 18, 2025, 7:34 PM EDT
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $5.41 billion as of August 18, 2025. Its market cap has increased by 9.92% in one year.
Market Cap
5.41B
Enterprise Value
4.40B
1-Year Change
9.92%
Ranking
Category
Stock Price
$75.05
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $5.41B, an increase of 579.50%. That is a compound annual growth rate of 60.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2025 | 5.41B | -2.76% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
| Jul 29, 2021 | 795.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 629.52B |
| Johnson & Johnson | 425.41B |
| AbbVie | 365.13B |
| UnitedHealth Group | 275.33B |
| AstraZeneca | 243.89B |
| Novartis AG | 239.15B |
| Abbott Laboratories | 229.31B |
| Novo Nordisk | 227.24B |